NOT-HL-18-594: Notice of Change to Instructions for Application Submission for RFA-HL-19-002 "Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)"

Notice of Change to Instructions for Application Submission for RFA-HL-19-002 "Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)"

Notice Number: NOT-HL-18-594

Key Dates
Release Date: February 8, 2018

Related Announcements
RFA-HL-19-002

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On January 30, 2018, NHLBI issued RFA-HL-19-002 "Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)". The purpose of this Notice is to clarify the number of applications allowed per institution.

Section III. Eligibility Information

3. Additional Information on Eligibility

Number of Applications

Current Language:
Applicant organizations may submit more than one application, provided that each application is scientifically distinct. Only one SI application per institution will be funded per DUNS number.

Revised Language:
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Josephine Boyington, Ph.D., MPH, CNS
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0446
Email: boyingtonje@mail.nih.gov